Abstract
Originalsprog | Engelsk |
---|---|
Tidsskrift | Human Molecular Genetics |
Vol/bind | 18 |
Udgave nummer | 12 |
Sider (fra-til) | 2297-304 |
Antal sider | 7 |
ISSN | 0964-6906 |
DOI | |
Status | Udgivet - 2009 |
Bibliografisk note
Keywords: Breast Neoplasms; Case-Control Studies; European Continental Ancestry Group; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glycoproteins; Humans; Neuropeptides; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Risk FactorsAdgang til dokumentet
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. / Song, Honglin; Ramus, Susan J; Kjaer, Susanne Krüger; DiCioccio, Richard A; Chenevix-Trench, Georgia; Pearce, Celeste Leigh; Hogdall, Estrid; Whittemore, Alice S; McGuire, Valerie; Hogdall, Claus; Blaakaer, Jan; Wu, Anna H; Van Den Berg, David J; Stram, Daniel O; Menon, Usha; Gentry-Maharaj, Aleksandra; Jacobs, Ian J; Webb, Penny M; Beesley, Jonathan; Chen, Xiaoqing; Australian Cancer (Ovarian) Study; Australian Ovarian Cancer Study Group; Rossing, Mary Anne; Doherty, Jennifer A; Chang-Claude, Jenny; Wang-Gohrke, Shan; Goodman, Marc T; Lurie, Galina; Thompson, Pamela J; Carney, Michael E; Ness, Roberta B; Moysich, Kirsten; Goode, Ellen L; Vierkant, Robert A; Cunningham, Julie M; Anderson, Stephanie; Schildkraut, Joellen M; Berchuck, Andrew; Iversen, Edwin S; Moorman, Patricia G; Garcia-Closas, Montserrat; Chanock, Stephen; Lissowska, Jolanta; Brinton, Louise; Anton-Culver, Hoda; Ziogas, Argyrios; Brewster, Wendy R; Ponder, Bruce A J; Easton, Douglas F; Gayther, Simon A; Pharoah, Paul D P; Ovarian Cancer Association Consortium (OCAC).
I: Human Molecular Genetics, Bind 18, Nr. 12, 2009, s. 2297-304.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study
AU - Song, Honglin
AU - Ramus, Susan J
AU - Kjaer, Susanne Krüger
AU - DiCioccio, Richard A
AU - Chenevix-Trench, Georgia
AU - Pearce, Celeste Leigh
AU - Hogdall, Estrid
AU - Whittemore, Alice S
AU - McGuire, Valerie
AU - Hogdall, Claus
AU - Blaakaer, Jan
AU - Wu, Anna H
AU - Van Den Berg, David J
AU - Stram, Daniel O
AU - Menon, Usha
AU - Gentry-Maharaj, Aleksandra
AU - Jacobs, Ian J
AU - Webb, Penny M
AU - Beesley, Jonathan
AU - Chen, Xiaoqing
AU - Australian Cancer (Ovarian) Study
AU - Australian Ovarian Cancer Study Group
AU - Rossing, Mary Anne
AU - Doherty, Jennifer A
AU - Chang-Claude, Jenny
AU - Wang-Gohrke, Shan
AU - Goodman, Marc T
AU - Lurie, Galina
AU - Thompson, Pamela J
AU - Carney, Michael E
AU - Ness, Roberta B
AU - Moysich, Kirsten
AU - Goode, Ellen L
AU - Vierkant, Robert A
AU - Cunningham, Julie M
AU - Anderson, Stephanie
AU - Schildkraut, Joellen M
AU - Berchuck, Andrew
AU - Iversen, Edwin S
AU - Moorman, Patricia G
AU - Garcia-Closas, Montserrat
AU - Chanock, Stephen
AU - Lissowska, Jolanta
AU - Brinton, Louise
AU - Anton-Culver, Hoda
AU - Ziogas, Argyrios
AU - Brewster, Wendy R
AU - Ponder, Bruce A J
AU - Easton, Douglas F
AU - Gayther, Simon A
AU - Pharoah, Paul D P
AU - Ovarian Cancer Association Consortium (OCAC)
N1 - Keywords: Breast Neoplasms; Case-Control Studies; European Continental Ancestry Group; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Glycoproteins; Humans; Neuropeptides; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Risk Factors
PY - 2009
Y1 - 2009
N2 - Because both ovarian and breast cancer are hormone-related and are known to have some predisposition genes in common, we evaluated 11 of the most significant hits (six with confirmed associations with breast cancer) from the breast cancer genome-wide association study for association with invasive ovarian cancer. Eleven SNPs were initially genotyped in 2927 invasive ovarian cancer cases and 4143 controls from six ovarian cancer case-control studies. Genotype frequencies in cases and controls were compared using a likelihood ratio test in a logistic regression model stratified by study. Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly associated with ovarian cancer risk and one SNP (rs4954956 in NXPH2) was associated with serous ovarian cancer in non-Hispanic white subjects (P-trend < 0.1). These four SNPs were then genotyped in an additional 4060 cases and 6308 controls from eight independent studies. Only rs4954956 was significantly associated with ovarian cancer risk both in the replication study and in combined analyses. This association was stronger for the serous histological subtype [per minor allele odds ratio (OR) 1.07 95% CI 1.01-1.13, P-trend = 0.02 for all types of ovarian cancer and OR 1.14 95% CI 1.07-1.22, P-trend = 0.00017 for serous ovarian cancer]. In conclusion, we found that rs4954956 was associated with increased ovarian cancer risk, particularly for serous ovarian cancer. However, none of the six confirmed breast cancer susceptibility variants we tested was associated with ovarian cancer risk. Further work will be needed to identify the causal variant associated with rs4954956 or elucidate its function.
AB - Because both ovarian and breast cancer are hormone-related and are known to have some predisposition genes in common, we evaluated 11 of the most significant hits (six with confirmed associations with breast cancer) from the breast cancer genome-wide association study for association with invasive ovarian cancer. Eleven SNPs were initially genotyped in 2927 invasive ovarian cancer cases and 4143 controls from six ovarian cancer case-control studies. Genotype frequencies in cases and controls were compared using a likelihood ratio test in a logistic regression model stratified by study. Initially, three SNPs (rs2107425 in MRPL23, rs7313833 in PTHLH, rs3803662 in TNRC9) were weakly associated with ovarian cancer risk and one SNP (rs4954956 in NXPH2) was associated with serous ovarian cancer in non-Hispanic white subjects (P-trend < 0.1). These four SNPs were then genotyped in an additional 4060 cases and 6308 controls from eight independent studies. Only rs4954956 was significantly associated with ovarian cancer risk both in the replication study and in combined analyses. This association was stronger for the serous histological subtype [per minor allele odds ratio (OR) 1.07 95% CI 1.01-1.13, P-trend = 0.02 for all types of ovarian cancer and OR 1.14 95% CI 1.07-1.22, P-trend = 0.00017 for serous ovarian cancer]. In conclusion, we found that rs4954956 was associated with increased ovarian cancer risk, particularly for serous ovarian cancer. However, none of the six confirmed breast cancer susceptibility variants we tested was associated with ovarian cancer risk. Further work will be needed to identify the causal variant associated with rs4954956 or elucidate its function.
U2 - 10.1093/hmg/ddp138
DO - 10.1093/hmg/ddp138
M3 - Journal article
C2 - 19304784
VL - 18
SP - 2297
EP - 2304
JO - Human Molecular Genetics
JF - Human Molecular Genetics
SN - 0964-6906
IS - 12
ER -